Analysis shows the involvement of androgens and inflammation in BPH pathophysiology, indicating complexities in treatment.
BPH is a nonmalignant proliferative disorder characterized by progressive enlargement of the prostate gland, involving both stromal and epithelial components. The growth primarily arises from the proliferation of fibroblasts/myofibroblasts and glandular epithelial cells localized in the transition zone surrounding the urethra. Histologically, BPH presents as a multifocal process with heterogeneous tissue composition, featuring varying degrees of stromal nodules and glandular hyperplasia. Understanding this evolving pathophysiology is crucial for guiding treatment and improving patient outcomes.
No takes yet. Share an insight, caveat, or question.
Maldonado et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: